Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice (Q46954005)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 October 2007

Language	Label	Description	Also known as
English	Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice	scientific article published on 12 October 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

1 reference

based on heuristic

inferred from title

author name string

Martina Hubensack

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

Christine Müller

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

Peter Höcherl

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

Stephan Fellner

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

Thilo Spruss

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

Günther Bernhardt

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

Armin Buschauer

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

publication date

12 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

134

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

597-607

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00432-007-0323-9

21 January 2018

Vincristine-resistant human cancer KB cell line and increased expression of multidrug-resistance gene

1 reference

https://api.crossref.org/works/10.1007%2FS00432-007-0323-9

21 January 2018

Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833

1 reference

https://api.crossref.org/works/10.1007%2FS00432-007-0323-9

21 January 2018

Targeting multidrug resistance in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of drug transporters at the blood-brain barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of paclitaxel in the treatment of primary and metastatic brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of paclitaxel and metabolites in mouse plasma, tissues, urine and faeces by semi-automated reversed-phase high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and Activity against Multidrug Resistance in Chinese Hamster Ovary Cells of New Acridone-4-carboxamides

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing safety and efficacy of directed P-glycoprotein inhibition to improve the pharmacokinetic properties of saquinavir coadministered with ritonavir

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug resistance in brain diseases and the role of drug efflux transporters.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GF120918, a P-glycoprotein modulator, increases the concentration of unbound amprenavir in the central nervous system in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug delivery to brain via the blood-brain barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical pharmacokinetic properties of the P-glycoprotein inhibitor GF120918A (HCl salt of GF120918, 9,10-dihydro-5-methoxy-9-oxo-N-[4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]phenyl]-4-acridine-carboxamide) in the mouse, rat, d

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of P-glycoprotein at blood-tissue barriers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of p-glycoprotein transport function at the blood-brain barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New drugs in recurrent high grade gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorescent cellular indicators are extruded by the multidrug resistance protein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17932689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-007-0323-9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17932689

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46954005&oldid=2208295933"